Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by GSK .
Filed returns
41
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2026 | GSK | Health | HIV Policy (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2026 | GSK | Health | Biotech Act, Respiratory and Oncology policy at EU level (Legislation) | 1 | On lobbying.ie |
| May–Aug 2026 | GSK | Health | Vaccines policy (Public policy or programme) | 21 | On lobbying.ie |
| May–Aug 2026 | GSK | Health | Vaccines policy (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2026 | GSK | Health | Adult immunisation policy (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2026 | GSK | Health | HIV treatment and prevention (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | GSK | Health | Information regarding HIV in Ireland (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | GSK | Health | Shingles Immunisation policy (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2025 | GSK | EU Affairs | General Pharmaceutical Legislation (Legislation) | 2 | On lobbying.ie |
| Sep–Dec 2025 | GSK | Health | Immunisation against RSV (Public policy or programme) | 11 | On lobbying.ie |
| May–Aug 2025 | GSK | Health | Vaccination policy (Public policy or programme) | 20 | On lobbying.ie |
| May–Aug 2025 | GSK | Health | Investment in treatment of HIV (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2025 | GSK | Health | Access and reimbursement timelines for medicines (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | GSK | EU Affairs | Meeting to discuss themes for Ireland's Council Presidency (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | GSK | Health | Sustainability in Life Sciences (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | GSK | Health | Immunisation policy (Public policy or programme) | 23 | On lobbying.ie |
| Jan–Apr 2025 | GSK | Health | Immunisation policy (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2025 | GSK | Health | Immunisation policy (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2024 | GSK | Health | Adult, RSV and Shingles Vaccination policy (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2024 | GSK | Health | Shingles vaccination policy (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | GSK | Health | Older adults RSV pathfinder programme (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2024 | GSK | Health | Vaccination policy (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2024 | GSK | Health | To demonstrate return on investment from adult vaccination (Public policy or programme) | 22 | On lobbying.ie |
| May–Aug 2024 | GSK | Health | Update on reimbursement process for Jemperli (Matters involving public funds) | 2 | On lobbying.ie |
| May–Aug 2024 | GSK | Health | RSV vaccination for older adults (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2024 | GSK | Health | Shingles vaccination for older adults (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2024 | GSK | Health | Adult vaccination (Public policy or programme) | 193 | On lobbying.ie |
| Jan–Apr 2024 | GSK | Health | Shingles vaccination (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | GSK | Health | EU legislation (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | GSK | Health | Immunisation policy (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2024 | GSK | Health | Immunisation policy (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | GSK | Health | Immunisation policy (Public policy or programme) | 15 | On lobbying.ie |
| May–Aug 2023 | GSK | Health | Diverting funds not spent on COVID (Matters involving public funds) | 2 | On lobbying.ie |
| May–Aug 2023 | GSK | Health | Immunisation policy (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2020 | GSK | Foreign Affairs | Request to Minister for Foreign Affairs Simon Coveney seeking clear guidance on the Northern Ireland Protocol (Legislation) | 5 | On lobbying.ie |
| Sep–Dec 2020 | GSK | Environment | GSK's sustainability commitment and how it relates to the Dungarvan manufacturing site (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2020 | GSK | Foreign Affairs | GSK lobbied the office of Minister for Foreign Affairs and Trade Simon Coveney regarding the pharmaceutical supply chain, specifically the supply of paracetamol from India. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2019 | GSK | Health | No specific piece of legislation. Rather a meeting around Slainte Care and chronic disease management (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2017 | GSK | EU Affairs | Brexit Implications (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2016 | GSK | Environment | GSK wrote to Mr Denis Naughten, TD, Minister for Communications, Climate Change and the Environment on November 22nd in respect of plans to introduce a Renewable Heath Initiative. We requested a meeting with the… (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2015 | GSK | Health | On October 2nd, 2015, GSK met with the Special Adviser assigned to the Minister for Health to discuss GSK's recent aquisition of Novartis' vaccines portfolio and the potential to broaden the National Immunisation… (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 34 | 82.9% | |
| EU Affairs | 3 | 7.3% | |
| Environment | 2 | 4.9% | |
| Foreign Affairs | 2 | 4.9% |